Published in Ann N Y Acad Sci on January 01, 1978
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92
Immunopotentiation of the humoral response by liposomes: encapsulation versus covalent linkage. Immunology (1988) 0.85
Altered pharmacological properties of liposome-associated human interferon-alpha. J Virol (1982) 0.83
Response of methylenetetrahydrofolate levels to methotrexate in Krebs ascites cells. Biochem J (1983) 0.80
High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J (2012) 0.80
Targeted endothelial nanomedicine for common acute pathological conditions. J Control Release (2015) 0.77
Plant glycosides in a liposomal drug-delivery system. Biochem J (1987) 0.76
The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem (1971) 3.73
Liposomes as immunological adjuvants. Nature (1974) 2.37
The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med (1976) 2.03
Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. Biochem J (1972) 1.97
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J (1980) 1.97
Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem (1972) 1.74
Drug entrapment in liposomes. FEBS Lett (1973) 1.73
Enzyme-containing liposomes alleviate a model for storage disease. Nature (1973) 1.63
Targeting of drugs. Nature (1977) 1.49
The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med (1976) 1.49
Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem (1970) 1.47
Homing of liposomes to target cells. Biochem Biophys Res Commun (1975) 1.46
Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci (1982) 1.40
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta (1991) 1.37
Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur J Biochem (1974) 1.28
Drug-carrier potential of liposomes in cancer chemotherapy. Lancet (1974) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Homing of liposomes to target cells. Biochem Soc Trans (1975) 1.20
Penetration of target areas in the rat by liposome-associated bleomycin, glucose oxidase and insulin. FEBS Lett (1976) 1.15
Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Biophys Res Commun (1979) 1.14
Targeting of drugs: implications in medicine. Lancet (1981) 1.13
Liposome-entrapped plasmid DNA: characterisation studies. Biochim Biophys Acta (2000) 1.09
Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol (1974) 1.08
Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology (1973) 1.08
The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett (1980) 1.08
Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine (2001) 1.07
Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett (1979) 1.06
Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine (1987) 1.06
Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. J Immunol (1989) 1.05
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. Life Sci (1977) 1.05
Decreased monoamine oxidase activity in liver of iron-deficient rats. Can J Biochem (1969) 1.03
Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response. Immunol Lett (1987) 1.03
Enzyme entrapment in liposomes. Methods Enzymol (1976) 1.03
Late postoperative results in males treated for testicular torsion during childhood. J Pediatr Surg (1994) 1.03
Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. Immunology (1987) 1.02
Liposomes as vehicles for the local release of drugs. Clin Sci Mol Med (1975) 1.01
Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Lett (1980) 1.00
Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett (1982) 1.00
Interaction of liposomes with blood plasma proteins. Biochem Soc Trans (1976) 0.98
Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. Biochem J (1974) 0.98
Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology (1988) 0.96
Novel sorbitan monostearate organogels. J Pharm Sci (1999) 0.96
Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta (1985) 0.95
Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase. Lancet (1977) 0.95
Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol (1975) 0.95
Preparation of liposomes containing factor VIII for oral treatment of haemophilia. J Microencapsul (1989) 0.93
Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochim Biophys Acta (1997) 0.92
Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta (1996) 0.90
Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochem J (1981) 0.90
Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target (1994) 0.89
Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet (1976) 0.89
Tissue and hepatic subcellular distribution of liposomes containing bleomycin after intravenous administration to patients with neoplasms. Clin Sci Mol Med (1976) 0.89
The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro. Life Sci (1980) 0.88
Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice. FEBS Lett (1974) 0.87
Tritiation of glycoproteins. Biochem Biophys Res Commun (1973) 0.86
Interaction of a nonionic surfactant-based organogel with aqueous media. Int J Pharm (1999) 0.85
Intracellular distribution of copper in the liver of the rat. Can J Biochem (1967) 0.85
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents: attempts to improve localization in tumour tissues [proceedings]. Biochem Soc Trans (1977) 0.85
Liposomes in the therapy of lysosomal storage diseases. Nature (1978) 0.85
Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci (1999) 0.85
Tumour regression with liposome-entrapped asparaginase: some immunological advantages. Biochem Soc Trans (1976) 0.84
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J (1971) 0.84
The use of monoclonal anti-Thy1 IgG1 for the targeting of liposomes to AKR-A cells in vitro and in vivo. Biochim Biophys Acta (1984) 0.84
Targeting of liposomes to accessible cells in vivo. Ann N Y Acad Sci (1985) 0.84
Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection. Hepatology (1998) 0.84
Penetration of target areas in the rat by liposome-associated agents administered parenterally and intragastrically. Biochem Soc Trans (1976) 0.84
Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice. Vaccine (1993) 0.83
Formation of hybrid liposomes from negatively and positively charged liposomes: a possible model for the study of membrane fusion. Biochem Soc Trans (1978) 0.83
Vaccines: recent trends and progress. Immunol Today (1990) 0.83
Rapid partial purification of placental glucocerebroside beta-glucosidase and its entrapment in liposomes. Biochem J (1977) 0.82
Old drugs in new clothing. Nature (1984) 0.82
Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively. Biochem J (1981) 0.81
Hepatitis-B-surface-antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen [proceedings]. Biochem Soc Trans (1979) 0.81
Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats. Biochim Biophys Acta (1996) 0.81
Preparation of glucocerebroside beta-glucosidase for entrapment in liposomes and treatment of patients with adult Gaucher's disease. Biochem Soc Trans (1976) 0.81
Tailoring liposome structure. Nature (1980) 0.81
Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives. J Pharm Biomed Anal (1997) 0.81
Synthesis, characterization and properties of sialylated catalase. Biochim Biophys Acta (1996) 0.81
Toxicity of sphingomyelin-containing liposomes after chronic injection into mice. Br J Exp Pathol (1983) 0.81
Antibody-coated liposomes. The role of non-specific antibody adsorption. FEBS Lett (1986) 0.81
Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors. Biochem J (1981) 0.81
Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators. Immunology (1989) 0.81
IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines. J Med Microbiol (1994) 0.80
Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase. Birth Defects Orig Artic Ser (1980) 0.80
The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. Int J Pharm (2001) 0.80
Incorporation of hepatitis-B surface antigen (HBsAg) into liposomes. Biochem Soc Trans (1978) 0.80
Role of protein in removal of copper from the liver. Nature (1968) 0.80
Morphological observations on liposomes bearing covalently bound protein: studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques. Biochim Biophys Acta (1998) 0.80
Fate of cholesterol-rich liposomes after subcutaneous injection into rats. Biochim Biophys Acta (1983) 0.80
Electron microscopic cytochemical localization of intravenously injected liposome-encapsulated horseradish peroxidase in rat liver cells. Adv Exp Med Biol (1976) 0.79
Entrapment of mRNA and rRNA into large monolamellar liposomes derived from hybrid small monolamellar liposomes. Biochem Soc Trans (1978) 0.78
Dehydration-rehydration vesicle methodology facilitates a novel approach to antibody binding to liposomes. Biochim Biophys Acta (1989) 0.78
Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. Invest Radiol (1988) 0.78
Liposomes as immunological adjuvants. Recent Results Cancer Res (1976) 0.78
Comparison of the immune response against polio peptides covalently-surface-linked to and internally-entrapped in liposomes. Asian Pac J Allergy Immunol (1991) 0.78
Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: vesicle characterization and in vivo behaviour. Biochim Biophys Acta (1994) 0.78
The effect of lipid composition on the stability of liposomes in vivo [proceedings]. Biochem Soc Trans (1979) 0.77
A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: potential uses in drug and vaccine delivery. J Drug Target (1995) 0.77
Stability and clearance of small unilamellar liposomes. Studies with normal and lipoprotein-deficient mice. Biochim Biophys Acta (1983) 0.77
Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens? Eur J Pharm Sci (1999) 0.77